Atlas Trials

A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Clinical trial NCT03075462 · COMPLETED

Trial details

NCT number
NCT03075462
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerTriple Negative Breast Cancer
Start date
2017-03-09
Primary completion
2021-08-22
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.